{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:18:52Z","timestamp":1771237132468,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570049"],"award-info":[{"award-number":["81570049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Respiratory J"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Objective<\/jats:title><jats:p>Bosentan therapy has been recommended for pulmonary arterial hypertension (PAH) and might be beneficial for chronic thromboembolic pulmonary hypertension (CTEPH). We aimed to evaluate the specific effects of bosentan for PAH and CTEPH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>We performed a systemic review and meta\u2010analysis of randomized controlled trials (RCTs), comparing efficacy and safety of bosentan treatment for PAH and CTEPH through major biomedical database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 10 RCTs including 1185 patients were enrolled. For PAH patients, bosentan prolonged 6\u2010minute walk distance with a weighted mean difference of 35.7\u00a0m, reduced mean pulmonary arterial pressure by 5.7\u00a0mm Hg, increased cardiac index by 0.4\u00a0L\/min\/m<jats:sup>2<\/jats:sup>, reduced pulmonary vascular resistance by 305.1\u00a0dyn\u00b7s\/cm<jats:sup>5<\/jats:sup>, prevented functional class from deterioration and reduced clinical worsening as compared with placebo. For CTEPH patients, bosentan improved cardiac index by 0.3\u00a0L\/min\/m<jats:sup>2<\/jats:sup> and reduced pulmonary vascular resistance by 176.0\u00a0dyn\u00b7s\/cm<jats:sup>5<\/jats:sup>. Other efficacy outcomes regarding CTEPH did not attain statistical difference. For both PAH and CTEPH, there was no significant difference in mortality or adverse event between bosentan and placebo group. However, bosentan raised the risk of abnormal liver function in both PAH and CTEPH patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Bosentan is effective in treating PAH, whereas it improves only certain hemodynamic parameters of CTEPH. Incidence of liver function abnormality is higher in bosentan treatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/crj.12774","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T10:52:38Z","timestamp":1517568758000},"page":"2065-2074","source":"Crossref","is-referenced-by-count":31,"title":["Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta\u2010analysis"],"prefix":"10.1111","volume":"12","author":[{"given":"Xinwang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine China\u2010Japan Friendship Hospital Beijing China"},{"name":"The Center of Respiratory Diseases, China\u2010Japan Friendship Hospital Beijing China"},{"name":"Department of Medicine, Peking University Health Science Center Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-8792","authenticated-orcid":false,"given":"Zhenguo","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine China\u2010Japan Friendship Hospital Beijing China"},{"name":"The Center of Respiratory Diseases, China\u2010Japan Friendship Hospital Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine China\u2010Japan Friendship Hospital Beijing China"},{"name":"The Center of Respiratory Diseases, China\u2010Japan Friendship Hospital Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanmu","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine China\u2010Japan Friendship Hospital Beijing China"},{"name":"The Center of Respiratory Diseases, China\u2010Japan Friendship Hospital Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine China\u2010Japan Friendship Hospital Beijing China"},{"name":"The Center of Respiratory Diseases, China\u2010Japan Friendship Hospital Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine China\u2010Japan Friendship Hospital Beijing China"},{"name":"The Center of Respiratory Diseases, China\u2010Japan Friendship Hospital Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035488"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2003.11.026"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60658"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.540"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2013.28.6.701"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.059"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.03.053"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.103.3.685"},{"key":"e_1_2_10_10_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins JPT","year":"2011"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06250-X"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.630715"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60919-8"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00028404"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02044-2014"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.01.057"},{"issue":"8","key":"e_1_2_10_17_1","first-page":"93","article-title":"The Efficacy of oral bosentan before and after the closure on patients with congenital heart disease and pulmonary shunt induced pulmonary arterial hypertension","volume":"31","author":"Lu Y","year":"2010","journal-title":"Journal of Kunming Medical University."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012212"},{"issue":"5","key":"e_1_2_10_19_1","first-page":"638","article-title":"Safety and tolerability evaluation of oral bosentan in adult congenital heart disease associated pulmonary arterial hypertension: a systematic review and meta\u2010analysis","volume":"18","author":"Guo L","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-016-9928-6"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0971"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.1.247"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2011.04.016"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.01.007"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00135905"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.4.2599"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000093322"},{"issue":"41","key":"e_1_2_10_28_1","first-page":"573","article-title":"Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH\u2010Study)","volume":"137","author":"Ulrich S","year":"2007","journal-title":"Swiss Med Wkly."},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00138706"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00121-9"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.12.179"}],"container-title":["The Clinical Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcrj.12774","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/crj.12774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T10:15:01Z","timestamp":1694945701000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/crj.12774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1111\/crj.12774"],"URL":"https:\/\/doi.org\/10.1111\/crj.12774","archive":["Portico"],"relation":{},"ISSN":["1752-6981","1752-699X"],"issn-type":[{"value":"1752-6981","type":"print"},{"value":"1752-699X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]}}}